NCT05575648

Brief Summary

This study was planned to determine the effects of the dual-task performance of children with DMD with motor dysfunction and varying degrees of cognitive impairment compared to their healthy peers, to compare the dual-task performance of children with different functional levels, and to determine the relationship between parameters that may affect dual-task performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 8, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

October 8, 2022

Last Update Submit

February 26, 2024

Conditions

Keywords

Duchenne Muscular DystrophyDual taskBalanceGait

Outcome Measures

Primary Outcomes (3)

  • Dual task performance- 10 meter walk test

    The time is measured after 10 meter walk completed

    only baseline

  • Dual task performance- 10 meter walk test with cognitive task

    The time is measured after 10 meter walk with a cognitive (memory and mental) task completed

    only baseline

  • Dual task performance- 10 meter walk test with motor task

    The time is measured after 10 meter walk with a motor task completed

    only baseline

Secondary Outcomes (14)

  • Functional level- Brooke Lower Extremity Functional Classification

    only baseline

  • Ambulation level- North star ambulatory assessment

    only baseline

  • Performance- 6 minutes walk test

    only baseline

  • Balance - Pediatric berg balance scale

    only baseline

  • Balance - Four square step test

    only baseline

  • +9 more secondary outcomes

Study Arms (2)

Duchenne Muscular Dystrophy

OTHER

Children who have been diagnosed with Duchenne Muscular Dystrophy.

Other: 10 meter walk test

Healthy Subjects

ACTIVE COMPARATOR

Children who have a normal motor and cognitive development.

Other: 10 meter walk test

Interventions

To assess the dual task performance of children 10 meter walk test will be used.

Duchenne Muscular DystrophyHealthy Subjects

Eligibility Criteria

Age6 Years+
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with DMD by a pediatric neurologist,
  • Must be at least 6 years old and have the ability to walk 10 meters independently,
  • Being able to cooperate with the instructions given by the physiotherapist,
  • Not having undergone surgery in the last 6 months and not having any injuries,

You may not qualify if:

  • Failure to cooperate with the physiotherapist who made the evaluations,
  • Have had any injury and/or surgery in the last 6 months,
  • Children without consent will not be included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Oznur YILMAZ, Prof

    Hacetteoe University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD candidate

Study Record Dates

First Submitted

October 8, 2022

First Posted

October 12, 2022

Study Start

September 6, 2022

Primary Completion

April 1, 2023

Study Completion

May 1, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations